Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
BGI Tech, the contract sequencing division of Shenzhen...
China is Asia’s number one biopharma cluster,...
China's Waterstone Pharma in-licensed global rights to a...
Guizhou Xinbang Pharma acquired Chinese Peptide Company...
Biotech Takes Third Loss in a Row. More details...
Vioxx puts another nail in the Blockbuster Drug Coffin....
Medarex could get as much as $610MM to develop 50...
Onyx gets milestone payment from partner Pfizer. More...
There could be a big upside in the generics battle. More...
Bioinformatics, once the promise of drug discovery, is...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
